Will joined Insmed in 2012 as President and Chief Executive Officer and as a member of the board of directors. He became Chair of the Board of Directors in November 2018. Will is the former Co-Founder, President, and Chief Financial Officer of Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR), and previously spent more than 10 years working in investment banking in the U.S. and Europe. He also previously worked for the U.S. government.
Will holds a Bachelor of Arts degree cum laude from Oberlin College as well as a Master of Business Administration and a Juris Doctor with Honors from Case Western Reserve University. Will is the Chair of the board of directors of NewAmsterdam Pharma (Nasdaq: NAMS) and a member of the board of directors of the Biotechnology Innovation Organization. He also sits on the Washington Post Intelligence Healthcare Council.
Your Privacy Choices